Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited

Eur J Neurol. 2018 Jul;25(7):905-906. doi: 10.1111/ene.13658. Epub 2018 May 3.

Authors

C S Constantinescu¹, P Gershkovich²

Affiliations

¹ Division of Clinical Neuroscience, School of Medicine and School of Pharmacy, University of Nottingham, Nottingham, UK.
² University of Nottingham, Nottingham, UK.

PMID: 29633480
DOI: 10.1111/ene.13658

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cannabidiol
Cannabinoids*
Down-Regulation
Dronabinol
Drug Combinations
Humans
Immunomodulation
Multiple Sclerosis*

Substances

Cannabinoids
Drug Combinations
Cannabidiol
Dronabinol
nabiximols